Show menu

About us

image

OUR MISSION

CELLforCURE by SEQENS provides complete, customized solutions for the development and manufacturing of cell and gene therapies, supporting our partners in accelerating their projects.

Our History

2010-2018
Creation by LFB
  • Opening of the GMP site at Les Ulis in 2014
  • ANSM (French branch EMA) approval for C&G manufacturing in 2015
  • GMP certificate in 2016
2018
Acquisition by Novartis
  • Commercial production of autologous CAR-T cells
2023
Acquisition by SEQENS
  • CELLforCURE by SEQENS: CDMO for clinical and Commercial Cell&Gene therapies
OUR CULTURE
CELLforCURE by SEQENS, our mindset and ways of working are guided by our customer satisfaction objective. Our partnership and collaborative approach results from 10 years of real-life Cell and Gene experience.

SEQENS group’s values are :
  • Entrepreneurship
  • Unity
  • Customer focus
  • Tenacity
  • Agility & reactivty
Read more
OUR EXPERTISE
CELLforCURE by SEQENS’ expertise stems from a dual background of CDMO and large-scale commercial manufacturing.

10 years of technology transfer expertise on multiple cell types delivered across Europe.
Learn more
image

Leadership Team

LT
Leadership Team

CELLforCURE by SEQENS Leadership Team

image
Pierre-Noël
Lirsac
President of CELLforCURE SAS and Chief Executive Officer
image
Hélène
Negre
Responsible Pharmacist and Pharmaceutical Affairs Director
image
Marc-Olivier
Mignon
Chief Commercial Officer
image
Najia
Glaserman
Project Director
image
Nathalie
Lelot
Chief Operating Officer
image
Aurélie
Kerveadou
Human Resources Director
image

Scientific committee

Sc
Scientific committee

CELLforCURE by SEQENS
Scientific Committee Members

image
Pascale
Bouillé
Cell and Gene Therapy consulting at LivyBio
image
Olivier
Danos
Executive Vice President and Chief Scientific Officer of REGENXBIO Inc.
image
Annelise
Bennaceur-Griscelli
Professor of Onco-Hematology at Paris Saclay University and Director of CiTHERA
image
Dr
Philippe
Menasché
Cardiac surgeon & Professor of Thoracic and Cardiovascular Surgery at the Université Paris-Cité
image
Sebastian
Amigorena
Director of the Center of Immunotherapy for cancers and the Immune responses and cancer Team at Institut Curie
image
Christian
Jorgensen
Professor and Director, IRMB and IHU Immun4cure at the Montpellier University Hospital